TrialPanorama/TrialPanorama-database huggingface dataset:
Study: 20231783

Group type: EXPERIMENTAL
Intervention: DMST (dynamic muscular stabilization techniques)
Number of subjects: 141

Group type: COMPARATOR
Intervention: CONV (conventional treatment)
Number of subjects: 141
Study: 18042917

Group type: EXPERIMENTAL
Intervention: GIK infusion therapy
Number of subjects: 2748
Study: 16518521

Group type: EXPERIMENTAL
Intervention: Propionylcarnitine (PLC) 600 mg as a single bolus followed by 1 mg/kg/min for 60 minutes
Number of subjects: 36

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 36

Group type: EXPERIMENTAL
Intervention: Propionylcarnitine (PLC)
Number of subjects: 36
Study: 14557150

Group type: EXPERIMENTAL
Intervention: CRA + vouchers
Number of subjects: 100

Group type: COMPARATOR
Intervention: Vouchers only
Number of subjects: 100
Study: 10617697

Group type: EXPERIMENTAL
Intervention: Maternal fever >100.4 degrees F
Number of subjects: 1218

Group type: EXPERIMENTAL
Intervention: Maternal fever >101 degrees F
Number of subjects: 1218

Group type: EXPERIMENTAL
Intervention: Maternal fever
Number of subjects: 1218

Group type: COMPARATOR
Intervention: Afebrile women
Number of subjects: 1218
Study: 9104600

Group type: EXPERIMENTAL
Intervention: Clonidine (1.5 micrograms/kg)
Number of subjects: 13

Group type: EXPERIMENTAL
Intervention: Clonidine (1.3 micrograms/kg)
Number of subjects: 13

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 13
Study: 8265735

Group type: EXPERIMENTAL
Intervention: GHRH
Number of subjects: 10
Study: 2863674

Group type: EXPERIMENTAL
Intervention: Chloramphenicol alone by intramuscular injection
Number of subjects: 367

Group type: COMPARATOR
Intervention: Chloramphenicol plus penicillin by intravenous injection
Number of subjects: 367
Study: 31504417

Group type: EXPERIMENTAL
Intervention: Canakinumab (50 mg)
Number of subjects: 4848

Group type: EXPERIMENTAL
Intervention: Canakinumab (150 mg)
Number of subjects: 4848

Group type: EXPERIMENTAL
Intervention: Canakinumab (300 mg)
Number of subjects: 4848

Group type: EXPERIMENTAL
Intervention: Canakinumab (any dose)
Number of subjects: 4848

Group type: EXPERIMENTAL
Intervention: IL-18 (measured 3 months after canakinumab initiation)
Number of subjects: 4848

Group type: EXPERIMENTAL
Intervention: IL-6 (measured 3 months after canakinumab initiation)
Number of subjects: 4848

Group type: EXPERIMENTAL
Intervention: IL-18 and IL-6 (baseline and on-treatment analyses)
Number of subjects: 4848

Group type: COMPARATOR
Intervention: Canakinumab
Number of subjects: 4848
Study: 29723901

Group type: EXPERIMENTAL
Intervention: Metoclopramide and Diphenhydramine (MAD)
Number of subjects: 70

Group type: COMPARATOR
Intervention: Codeine
Number of subjects: 70
Study: 27810185

Group type: EXPERIMENTAL
Intervention: Effective CPAP for six weeks
Number of subjects: 36

Group type: COMPARATOR
Intervention: Sham CPAP for six weeks
Number of subjects: 36
Study: 24284234

Group type: EXPERIMENTAL
Intervention: Olanzapine
Number of subjects: 614

Group type: COMPARATOR
Intervention: Perphenazine
Number of subjects: 614

Group type: COMPARATOR
Intervention: Quetiapine
Number of subjects: 614

Group type: COMPARATOR
Intervention: Ziprasidone
Number of subjects: 614

Group type: COMPARATOR
Intervention: Risperidone
Number of subjects: 614
Study: 22631861

Group type: EXPERIMENTAL
Intervention: Aggressive recruitment tactics including hiring a recruitment director, expanding sites, and broadening eligibility criteria.
Number of subjects: 2502

Group type: EXPERIMENTAL
Intervention: Recruitment tactics implemented from 2004 to 2008.
Number of subjects: 2502

Group type: EXPERIMENTAL
Intervention: Recruitment tactics implemented in 2006, 2007, and 2008.
Number of subjects: 2502
Study: 20171327

Group type: EXPERIMENTAL
Intervention: Cognitive-behavioral therapy (CBT)
Number of subjects: 65

Group type: EXPERIMENTAL
Intervention: Applied relaxation (AR)
Number of subjects: 65

Group type: COMPARATOR
Intervention: Wait-list control (WL)
Number of subjects: 65
Study: 19066278

Group type: EXPERIMENTAL
Intervention: Anthracycline regimens
Number of subjects: 54189

Group type: EXPERIMENTAL
Intervention: Single-drug taxane
Number of subjects: 54189

Group type: EXPERIMENTAL
Intervention: Combination of anthracyclines with taxane
Number of subjects: 54189

Group type: EXPERIMENTAL
Intervention: Taxane-based combination with capecitabine or gemcitabine
Number of subjects: 54189

Group type: EXPERIMENTAL
Intervention: Molecular targeted treatments
Number of subjects: 54189
Study: 16188185

Group type: EXPERIMENTAL
Intervention: Running horizontal mattress suture
Number of subjects: 55

Group type: COMPARATOR
Intervention: Simple running suture
Number of subjects: 55
Study: 12592331

Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (HDMP) 900-600 mg/m(2) orally
Number of subjects: 205

Group type: COMPARATOR
Intervention: Conventional dose prednisolone 60 mg/m(2)/day orally
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (HDMP) in high-risk subgroup
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (HDMP) in high-risk subgroup aged </=2 or >/=10 years
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (HDMP) in high-risk subgroup with WBC count >/=50 x 10(9)/l
Number of subjects: 205

Group type: EXPERIMENTAL
Intervention: High-dose methylprednisolone (HDMP)
Number of subjects: 205
Study: 10229456

Group type: EXPERIMENTAL
Intervention: Group communication treatment (5 hours weekly for 4 months)
Number of subjects: 24

Group type: COMPARATOR
Intervention: Deferred treatment (support, performance, or movement groups)
Number of subjects: 24
Study: 8949808

Group type: EXPERIMENTAL
Intervention: Extradural anaesthesia in group I (no previous procedures)
Number of subjects: 491

Group type: COMPARATOR
Intervention: Extradural anaesthesia in group II (one previous procedure)
Number of subjects: 491

Group type: COMPARATOR
Intervention: Extradural anaesthesia in group III (two or more previous procedures)
Number of subjects: 491

Group type: COMPARATOR
Intervention: Flexible extraduroscopy in 32 patients
Number of subjects: 491
Study: 1806520

Group type: EXPERIMENTAL
Intervention: Transparent hydrocolloid dressing (THCD)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Traditional paraffin gauze dressing (PGD)
Number of subjects: 12
Study: 6616993

Group type: EXPERIMENTAL
Intervention: Tamoxifen
Number of subjects: 14

Group type: COMPARATOR
Intervention: Historical control group
Number of subjects: 14
Study: 31556095

Group type: EXPERIMENTAL
Intervention: milrinone (0.4 and 0.8 µg/kg/min, n = 16)
Number of subjects: 31

Group type: EXPERIMENTAL
Intervention: levosimendan (0.1 and 0.2 µg/kg/min, n = 15)
Number of subjects: 31
Study: 30145660

Group type: EXPERIMENTAL
Intervention: Coronectomy with adjunctive guided bone regeneration (GBR)
Number of subjects: 48

Group type: COMPARATOR
Intervention: Coronectomy alone (control group)
Number of subjects: 48

Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 48
Study: 28207503

Group type: EXPERIMENTAL
Intervention: Clamping drainage for the first 4 postoperative hours
Number of subjects: 121

Group type: COMPARATOR
Intervention: Nonclamping drainage
Number of subjects: 121
Study: 24980988

Group type: COMPARATOR
Intervention: Etanercept 50 mg BIW
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Etanercept 50 mg QW plus topical agent as needed
Number of subjects: 282

Group type: EXPERIMENTAL
Intervention: Both groups (Etanercept 50 mg BIW and Etanercept 50 mg QW plus topical agent)
Number of subjects: 282
Study: 23542053

Group type: EXPERIMENTAL
Intervention: Online game suite designed to train multiple cognitive abilities
Number of subjects: 60

Group type: COMPARATOR
Intervention: Control arm with online activities that simulated the games but with low level interactivity and no calibration of difficulty
Number of subjects: 60
Study: 21871624

Group type: EXPERIMENTAL
Intervention: Atorvastatin 20mg once daily
Number of subjects: 1255

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1255
Study: 17618526

Group type: EXPERIMENTAL
Intervention: Patients with avoidant personality disorder (APD)
Number of subjects: 335

Group type: COMPARATOR
Intervention: Patients without avoidant personality disorder (APD)
Number of subjects: 335

Group type: EXPERIMENTAL
Intervention: Presence of APD
Number of subjects: 335
Study: 16484170

Group type: EXPERIMENTAL
Intervention: Group supervision
Number of subjects: 23

Group type: COMPARATOR
Intervention: Individual supervision
Number of subjects: 23
Study: 15097153

Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (rhGH) 0.1 mg/kg daily (DD)
Number of subjects: 757

Group type: EXPERIMENTAL
Intervention: Recombinant human growth hormone (rhGH) 0.1 mg/kg alternate days (AD)
Number of subjects: 757

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 757
Study: 10696916

Group type: EXPERIMENTAL
Intervention: Interferon beta-1a (IFNbeta-1a) treatment for 6 months
Number of subjects: 0
Study: 9350882

Group type: EXPERIMENTAL
Intervention: High dose oral vitamin A supplementation
Number of subjects: 592

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 592
Study: 8223076

Group type: EXPERIMENTAL
Intervention: Lactogest (4 capsules, approx 6000 IU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Lactaid (2 caplets, approx 6000 IU)
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: DairyEase (2 tablets, approx 6000 IU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Lactogest (2 capsules, approx 3000 IU)
Number of subjects: 0

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Enzyme treatment (3000 or 6000 IU) with 50 g of lactose
Number of subjects: 0
Study: 2433872

Group type: EXPERIMENTAL
Intervention: 0.25% methotrexate cream
Number of subjects: 5

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 5
Study: 30871349

Group type: EXPERIMENTAL
Intervention: NT-proBNP levels in patients with AF
Number of subjects: 3835

Group type: COMPARATOR
Intervention: NT-proBNP levels in patients without AF
Number of subjects: 3835

Group type: EXPERIMENTAL
Intervention: Primary composite outcome of cardiovascular death or HF hospitalization in patients with AF
Number of subjects: 3835

Group type: COMPARATOR
Intervention: Primary composite outcome of cardiovascular death or HF hospitalization in patients without AF
Number of subjects: 3835

Group type: EXPERIMENTAL
Intervention: Adjusted analyses of NT-proBNP levels
Number of subjects: 3835

Group type: COMPARATOR
Intervention: NT-proBNP <400 pg/mL
Number of subjects: 3835

Group type: EXPERIMENTAL
Intervention: NT-proBNP ≥400 pg/mL
Number of subjects: 3835
Study: 30251591

Group type: EXPERIMENTAL
Intervention: High-dose ESS (1-hour daily during hospitalization)
Number of subjects: 102

Group type: COMPARATOR
Intervention: Low-dose ESS (placebo)
Number of subjects: 102
Study: 29064791

Group type: EXPERIMENTAL
Intervention: Quercetin at a dose of 120 mg per os daily added to standard treatment
Number of subjects: 85

Group type: COMPARATOR
Intervention: Standard treatment without quercetin
Number of subjects: 85
Study: 25603743

Group type: EXPERIMENTAL
Intervention: Pilates breathing technique (POW) during trunk flexion
Number of subjects: 19

Group type: COMPARATOR
Intervention: Trunk flexion without the Pilates breathing technique (NORM)
Number of subjects: 19
Study: 22093961

Group type: EXPERIMENTAL
Intervention: Sirolimus-eluting stent (SES)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Bare-metal stent (BMS)
Number of subjects: 320

Group type: COMPARATOR
Intervention: Sirolimus-eluting stent (SES) and Bare-metal stent (BMS)
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Patients who did not experience TLR within 1-year
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Patients who experienced TLR within 1-year
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: TLR within 1 year
Number of subjects: 320

Group type: EXPERIMENTAL
Intervention: Small vessels treatment
Number of subjects: 320
Study: 22015082

Group type: EXPERIMENTAL
Intervention: Coordinated discharge care organized by a discharge coordinator
Number of subjects: 0

Group type: COMPARATOR
Intervention: Usual care (control group)
Number of subjects: 0
Study: 18427699

Group type: EXPERIMENTAL
Intervention: Specific Resistance Training (SRT)
Number of subjects: 549

Group type: EXPERIMENTAL
Intervention: All-round Physical Exercise (APE)
Number of subjects: 549

Group type: COMPARATOR
Intervention: Reference group (general health-promoting activities)
Number of subjects: 549
Study: 16949939

Group type: EXPERIMENTAL
Intervention: Cervical high-velocity low-amplitude (HVLA) manipulation
Number of subjects: 70

Group type: COMPARATOR
Intervention: Control mobilization procedure
Number of subjects: 70
Study: 12734892

Group type: EXPERIMENTAL
Intervention: Various interventions in randomized controlled trials (RCT) on systemic lupus erythematosus (SLE)
Number of subjects: 2257

Group type: EXPERIMENTAL
Intervention: Nephritis trials
Number of subjects: 2257

Group type: EXPERIMENTAL
Intervention: Trials that specified withdrawals per arm
Number of subjects: 2257

Group type: EXPERIMENTAL
Intervention: Trials that used intention-to-treat analyses
Number of subjects: 2257

Group type: EXPERIMENTAL
Intervention: Trials published in 1999-2002
Number of subjects: 2257

Group type: EXPERIMENTAL
Intervention: Larger trials
Number of subjects: 2257

Group type: EXPERIMENTAL
Intervention: Trials that described reasons for withdrawals
Number of subjects: 2257
Study: 11601562

Group type: EXPERIMENTAL
Intervention: Diet Group (individual dietary counseling to increase intake of iron-rich foods)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Supplement Group (50 mg iron/day as amino acid chelate)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Placebo Group
Number of subjects: 75
Study: 9715679

Group type: EXPERIMENTAL
Intervention: Dorzolamide 2.0% three times daily
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Timolol 0.5% twice daily
Number of subjects: 298

Group type: EXPERIMENTAL
Intervention: Betaxolol 0.5% twice daily
Number of subjects: 298
Study: 7527106

Group type: EXPERIMENTAL
Intervention: Trandolapril 4 mg o.d.
Number of subjects: 180

Group type: COMPARATOR
Intervention: Captopril 50 mg b.i.d.
Number of subjects: 180

Group type: EXPERIMENTAL
Intervention: Trandolapril + HCTZ 25 mg (if needed)
Number of subjects: 180

Group type: COMPARATOR
Intervention: Captopril + HCTZ 25 mg (if needed)
Number of subjects: 180
Study: 2525984

Group type: EXPERIMENTAL
Intervention: Etodolac 200 mg three times a day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etodolac 300 mg twice a day
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Etodolac
Number of subjects: 0

Group type: COMPARATOR
Intervention: Piroxicam 20 mg once a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Diclofenac 50 mg three times a day
Number of subjects: 0

Group type: COMPARATOR
Intervention: Naproxen 500 mg twice a day
Number of subjects: 0
Study: 31514546

Group type: EXPERIMENTAL
Intervention: Tratinterol hydrochloride
Number of subjects: 732

Group type: COMPARATOR
Intervention: Procaterol hydrochloride (active control)
Number of subjects: 732
Study: 31190151

Group type: EXPERIMENTAL
Intervention: Tissue-engineered substitute for autologous oral mucosa
Number of subjects: 0

Group type: COMPARATOR
Intervention: Urethrotomy
Number of subjects: 0

Group type: COMPARATOR
Intervention: Injection of stem cells
Number of subjects: 0

Group type: COMPARATOR
Intervention: Alternative tissue-engineered substitute
Number of subjects: 0
Study: 28679430

Group type: EXPERIMENTAL
Intervention: Smoking cessation intervention, details not specified
Number of subjects: 0

Group type: COMPARATOR
Intervention: Not applicable
Number of subjects: 0
Study: 25803571

Group type: EXPERIMENTAL
Intervention: Weekly fractionated IPL
Number of subjects: 30

Group type: COMPARATOR
Intervention: Biweekly conventional IPL
Number of subjects: 30
Study: 23703134

Group type: EXPERIMENTAL
Intervention: Solvent-exposed subjects
Number of subjects: 48

Group type: COMPARATOR
Intervention: Non-exposed subjects
Number of subjects: 48
Study: 20962664

Group type: EXPERIMENTAL
Intervention: CAT stent
Number of subjects: 34

Group type: COMPARATOR
Intervention: DES
Number of subjects: 34

Group type: COMPARATOR
Intervention: BMS
Number of subjects: 34
Study: 19439758

Group type: EXPERIMENTAL
Intervention: Local corticosteroid injection (25 mg prednisolone)
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Home training
Number of subjects: 229

Group type: EXPERIMENTAL
Intervention: Radial shock wave therapy
Number of subjects: 229
Study: 17270320

Group type: EXPERIMENTAL
Intervention: Concomitant administration of Tdap and influenza vaccines
Number of subjects: 720

Group type: COMPARATOR
Intervention: Sequential administration of influenza vaccine followed by Tdap
Number of subjects: 720
Study: 15541248

Group type: EXPERIMENTAL
Intervention: Glucose-insulin-potassium infusion
Number of subjects: 20

Group type: COMPARATOR
Intervention: Standard care
Number of subjects: 20
Study: 11853286

Group type: EXPERIMENTAL
Intervention: Low-dose oral contraceptive (OC)
Number of subjects: 80

Group type: COMPARATOR
Intervention: Hormone replacement therapy (HRT)
Number of subjects: 80
Study: 9635651

Group type: EXPERIMENTAL
Intervention: Tusk mask
Number of subjects: 23

Group type: COMPARATOR
Intervention: Nonrebreather mask (NRM)
Number of subjects: 23
Study: 7835209

Group type: EXPERIMENTAL
Intervention: Vibratory stimulation for 5 minutes
Number of subjects: 59

Group type: COMPARATOR
Intervention: Control group (healthy volunteers)
Number of subjects: 59

Group type: EXPERIMENTAL
Intervention: Diabetic patients
Number of subjects: 59
Study: 31187169

Group type: EXPERIMENTAL
Intervention: Lapatinib 2000 mg
Number of subjects: 37

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 37
Study: 29027884

Group type: EXPERIMENTAL
Intervention: Handheld, nonmydriatic fundus camera (Pictor Plus; Volk Optical, Mentor, OH)
Number of subjects: 109
Study: 27466884

Group type: EXPERIMENTAL
Intervention: Weight-loss diets with different macronutrient compositions
Number of subjects: 711
Study: 25232119

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) activating anterior‐to‐posterior (AP) inputs
Number of subjects: 0

Group type: EXPERIMENTAL
Intervention: Transcranial magnetic stimulation (TMS) activating posterior‐to‐anterior (PA) inputs
Number of subjects: 0
Study: 22270979

Group type: EXPERIMENTAL
Intervention: Billroth I (B-I)
Number of subjects: 332

Group type: COMPARATOR
Intervention: Roux-en-Y (R-Y)
Number of subjects: 332
Study: 20879641

Group type: EXPERIMENTAL
Intervention: Dietary intervention providing specific dietary advice and ongoing motivational support during routine antenatal appointments
Number of subjects: 25
Study: 18596681

Group type: EXPERIMENTAL
Intervention: Pumped before drinking (PB)
Number of subjects: 16

Group type: EXPERIMENTAL
Intervention: Pumped after drinking (PA)
Number of subjects: 16
Study: 15826053

Group type: EXPERIMENTAL
Intervention: Phloem-fortified rye bread (62 mg catechins, high polyphenol, HP)
Number of subjects: 75

Group type: EXPERIMENTAL
Intervention: Phloem-fortified rye bread (31 mg catechins, low polyphenol, LP)
Number of subjects: 75

Group type: COMPARATOR
Intervention: Rye bread (placebo)
Number of subjects: 75
Study: 12860804

Group type: EXPERIMENTAL
Intervention: Eye black grease
Number of subjects: 46

Group type: EXPERIMENTAL
Intervention: Antiglare stickers
Number of subjects: 46

Group type: COMPARATOR
Intervention: Control (Petroleum jelly)
Number of subjects: 46
Study: 10391656

Group type: EXPERIMENTAL
Intervention: Studies meeting methodological quality criteria (explicit statement of random allocation, allocation concealment, double-blinding, completeness of follow-up)
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Studies scoring above predefined scores in quality assessment scales
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Cumulative meta-analysis of studies with lower-quality scores
Number of subjects: 89

Group type: EXPERIMENTAL
Intervention: Studies with better methodological quality
Number of subjects: 89
Study: 8554205

Group type: EXPERIMENTAL
Intervention: Intensive insulin therapy
Number of subjects: 153

Group type: COMPARATOR
Intervention: Standard insulin therapy
Number of subjects: 153
Study: 1876626

Group type: EXPERIMENTAL
Intervention: Atenolol 100 mg daily
Number of subjects: 11

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 11
Study: 6125185

Group type: EXPERIMENTAL
Intervention: Propranolol 160 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Atenolol 60 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pindolol 20 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Pindolol 5 mg
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Fenoterol (inhaled)
Number of subjects: 12

Group type: EXPERIMENTAL
Intervention: Histamine (inhaled)
Number of subjects: 12

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 12
Study: 30439998

Group type: EXPERIMENTAL
Intervention: New ergonomic wrap
Number of subjects: 96

Group type: COMPARATOR
Intervention: Traditional wrap
Number of subjects: 96
Study: 26666236

Group type: EXPERIMENTAL
Intervention: Bone marrow cell therapy
Number of subjects: 83

Group type: COMPARATOR
Intervention: Control (standard care)
Number of subjects: 83
Study: 25463819

Group type: EXPERIMENTAL
Intervention: Spanish instruction for 6 months
Number of subjects: 55

Group type: COMPARATOR
Intervention: Introductory Psychology (control group)
Number of subjects: 55
Study: 22615116

Group type: EXPERIMENTAL
Intervention: Home blood pressure telemonitoring with self-care support
Number of subjects: 110

Group type: COMPARATOR
Intervention: Control group (no intervention)
Number of subjects: 110

Group type: COMPARATOR
Intervention: Home blood pressure monitoring alone
Number of subjects: 110
Study: 20666265

Group type: EXPERIMENTAL
Intervention: Fluvastatin 40 mg/day
Number of subjects: 90

Group type: COMPARATOR
Intervention: Placebo (routine group)
Number of subjects: 90
Study: 19102428

Group type: EXPERIMENTAL
Intervention: 4.8-mm GIA universal stapler
Number of subjects: 60

Group type: COMPARATOR
Intervention: 3.5-mm GIA universal stapler
Number of subjects: 60
Study: 16260243

Group type: EXPERIMENTAL
Intervention: Audience response system interactive lectures
Number of subjects: 17

Group type: COMPARATOR
Intervention: Standard lecture
Number of subjects: 17
Study: 11804978

Group type: EXPERIMENTAL
Intervention: Intravenous fibrinolysis with alteplase
Number of subjects: 19

Group type: COMPARATOR
Intervention: Revascularization by stent placement with additional abciximab treatment
Number of subjects: 19
Study: 10546605

Group type: EXPERIMENTAL
Intervention: Midvastus approach
Number of subjects: 109

Group type: COMPARATOR
Intervention: Medial parapatellar approach
Number of subjects: 109
Study: 7552860

Group type: EXPERIMENTAL
Intervention: Pentoxifylline (400 mg orally, four times daily for 15 days)
Number of subjects: 10

Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 10
Study: 15374509

Group type: EXPERIMENTAL
Intervention: Cerebrolysin + multivitamin infusions
Number of subjects: 27

Group type: COMPARATOR
Intervention: Multivitamin infusions alone
Number of subjects: 27
Study: 6156059

Group type: EXPERIMENTAL
Intervention: IV gamma-globulin (GG) 20 g IV given postoperatively
Number of subjects: 0